Cardan Capital Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-14,125
Closed -$1.01M 189
2018
Q4
$1.01M Buy
14,125
+1,430
+11% +$115K 0.18% 92
2018
Q3
$1.22M Buy
12,695
+600
+5% +$58.2K 0.19% 86
2018
Q2
$1.15M Buy
12,095
+1,036
+9% +$95.2K 0.19% 84
2018
Q1
$970K Buy
+11,059
New +$1.01M 0.16% 87
2017
Q4
Sell
-7,680
Closed -$665K 127
2017
Q3
$665K Buy
7,680
+200
+3% +$16K 0.13% 76
2017
Q2
$577K Buy
7,480
+106
+1% +$7.52K 0.11% 77
2017
Q1
$511K Buy
7,374
+995
+16% +$66.8K 0.11% 79
2016
Q4
$378K Buy
6,379
+1,997
+46% +$123K 0.08% 82
2016
Q3
$290K Buy
+4,382
New +$271K 0.06% 90

Other funds holding XBI